Search results for "PERIPHERAL NEUROPATHY"

showing 10 items of 55 documents

Restless legs syndrome in a patient with multifocal motor neuropathy

2009

Restless legs syndrome (RLS) has been frequently reported in association with peripheral neuropathy, and it is especially frequent in some forms of polyneuropathy with preferential involvement of small sensory fibers. Here, we describe a patient with multifocal motor neuropathy, who developed RLS during the course of the disease. Our findings support the notion that RLS may develop in the context of immune-mediated neuropathies and it should be specifically investigated even in those patients with preferentially or exclusive motor involvement.

Malemedicine.medical_specialtyNeurologyContext (language use)DermatologyDiseasePhysical medicine and rehabilitationRestless Legs Syndromemental disordersmedicineHumansRestless legs syndromebusiness.industryPeripheral Nervous System DiseasesRestless legs syndrome motor neuropathyGeneral MedicineMiddle Agedmedicine.diseaseSurgeryPsychiatry and Mental healthPeripheral neuropathyDisease ProgressionSettore BIO/14 - FarmacologiaNeurology (clinical)NeurosurgerybusinessPolyneuropathyMultifocal motor neuropathyNeurological Sciences
researchProduct

Refsum disease. Clinical and morphological report on a case

1982

An atypical case of Refsum disease is reported together with the peripheral nerve morphological data. The body fluids must be assayed for phytanic acid whenever an atypical chronic peripheral neuropathy is observed.

Malemedicine.medical_specialtyPathologyNeurologyAdolescentPhytanic acidDermatologychemistry.chemical_compoundPeripheral nerveHumansMedicineNeuroradiologybusiness.industryGeneral NeuroscienceGeneral Medicinemedicine.diseaseChronic PolyneuropathyBody FluidsPhytanic AcidPsychiatry and Mental healthRefsum diseasePeripheral neuropathychemistryRefsum DiseaseNeurology (clinical)NeurosurgerybusinessThe Italian Journal of Neurological Sciences
researchProduct

Neurological complications of Anderson-Fabry disease

2012

Characteristic clinical manifestations of AFD such as acroparesthesias, angiokeratoma, corneal opacity, hypo/ and anhidrosis, gastrointestinal symptoms, renal and cardiac dysfunctions can occur in male and female patients, although heterozygous females with AFD usually seems to be less severely affected. The most prominent CNS manifestations consist of cerebrovascular events such as transient ischaemic attacks (TIAs) and (recurrent) strokes . For the most part, CNS complications in AFD have been attributed to cerebral vasculopathy, including anatomical abnormalities. The natural history of Fabry patients includes transitory cerebral ischaemia and strokes, even in very young persons of both …

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaPopulationTransient ischaemic attacksPulvinarSeverity of Illness IndexInternal medicineDrug DiscoverymedicinePrevalenceHumanseducationStrokeDepression (differential diagnoses)Pharmacologyeducation.field_of_studySex Characteristicsbusiness.industryAge Factorsmedicine.diseaseFabry diseaseHyperintensitySurgeryAngiokeratomaStrokePeripheral neuropathyIschemic Attack TransientCerebrovascular Circulationalpha-GalactosidaseCardiologyFabry DiseaseFemaleAnderson-Fabry disease Neurological strokebusiness
researchProduct

Diabetic Peripheral Neuropathy is Associated With Diabetic Kidney Disease and Cardiovascular Disease:The Silesia Diabetes-Heart Project

2023

Microvascular complications of diabetes seem to be clustered and put patients at higher risk of developing cardiovascular disease (CVD). This was a questionnaire-based study designed to screen for the presence of diabetic peripheral neuropathy (DPN), defined as the score in the Michigan Neuropathy Screening Instrument (MNSI) above 2, and to evaluate its association with other complication of diabetes, including CVD. There were 184 patients included into the study. The prevalence of DPN in the study group was 37.5%. The regression model analysis revealed that the presence of DPN was significantly associated with the presence of diabetic kidney disease (DKD) (P = 0.0034;) and patient's age (P…

Michigan Neuropathy Screening Instrument; cardiovascular disease; diabetes mellitus; diabetic kidney disease; diabetic peripheral neuropathyGeneral MedicineCardiology and Cardiovascular Medicine
researchProduct

Cancer chemotherapy in the older cancer patient.

2009

This article reviews the principles of systemic cancer treatment in older individuals. These include: assessment of physiologic age with a comprehensive geriatric assessment (CGA), adjustment of chemotherapy doses to the patient's renal function, and prevention of myelotoxicity with hemopoietic growth factors. Other complications that become more common with age include mucositis, peripheral neuropathy and cardiomyopathy. Two chronic complications of chemotherapy become more common with age, including myelodysplasia and chronic cardiomyopathy. The goal of systemic cancer treatment in the older person should include prolongation of active life-expectancy and compression of morbidity in addit…

Nephrologymedicine.medical_specialtyAgingSettore MED/06 - Oncologia MedicaUrologymedicine.medical_treatmentCardiomyopathySystemic treatmentAntineoplastic AgentsKidneyMedical OncologyPatient Care PlanningElderlyLife ExpectancyInternal medicineNeoplasmsmedicineMucositisChemotherapyHumansIntensive care medicineGeriatric AssessmentCancerAgedAged 80 and overChemotherapybusiness.industryKidney metabolismCancermedicine.diseasePeripheral neuropathyTreatment OutcomeOncologyCompression of morbiditybusinessUrologic oncology
researchProduct

Cell expression of GDAP1 in the nervous system and pathogenesis of Charcot-Marie-Tooth type 4A disease

2007

Abstract Mutations in the mitochondrial protein GDAP1 are the cause of Charcot-Marie-Tooth type 4A disease (CMT4A), a severe form of peripheral neuropathy associated with either demyelinating, axonal or intermediate pheno-types. GDAP1 is located in the outer mitochondrial membrane and it seems that may be related with the mitochondrial network dynamics. We are interested to define cell expression in the nervous system and the effect of mutations in mitochondrial morphology and pathogenesis of the disease. We investigated GDAP1 expression in the nervous system and dorsal root ganglia (DRG) neuron cultures. GDAP1 is expressed in motor and sensory neurons of the spinal cord and other large neu…

Nervous systemCMT4A mutations and pathogenesisPathologymedicine.medical_specialtyperipheral neuropathyCharcot-Marie-Tooth type 4A diseaseMutation MissenseGene ExpressionImages in Cellular / Molecular MedicineNerve Tissue ProteinsGDAP1MitochondrionBiologymedicine.disease_causeNervous SystemPathogenesisMicePurkinje CellsCharcot-Marie-Tooth DiseaseInterneuronsGanglia SpinalChlorocebus aethiopsmedicineAnimalsHumansNeurons AfferentCells CulturedMotor NeuronsMutationfusion and fission pathwayPyramidal CellsCell Biologymedicine.diseaseSpinal cordImmunohistochemistrymitochondrial dynamicsCell biologyOlfactory bulbRatsmedicine.anatomical_structurePeripheral neuropathynervous systemAnimals NewbornSpinal CordCOS CellsMolecular MedicineNeuronHeLa CellsJournal of Cellular and Molecular Medicine
researchProduct

A phase III trial of nab-paclitaxel versus dacarbazine in chemotherapy-naive patients (pts) with metastatic melanoma: Analysis of peripheral neuropat…

2013

e20025 Background: Peripheral neuropathy (PN) is a common side effect associated with taxane treatment. In a phase III trial, nab-paclitaxel vs dacarbazine demonstrated a significant improvement in progression-free survival (4.8 vs 2.5 months; P = 0.044) and at the interim survival analysis, a trend toward prolonged overall survival (12.8 vs 10.7 months; P = 0.094) for the treatment of chemotherapy-naive patients with metastatic melanoma. Here we report on the PN profile of nab-paclitaxel in this phase III trial. Methods: Pts (median age, 63 years) with chemotherapy-naive stage IV melanoma (M1c stage, 65%; elevated LDH, 28%) and an ECOG performance status 0-1 were randomized to nab-paclita…

OncologyCancer Researchmedicine.medical_specialtyPathologyTaxaneMetastatic melanomaSide effectbusiness.industryDacarbazinemedicine.diseasePeripheral neuropathyOncologyInternal medicinemedicinebusinessChemotherapy naiveNab-paclitaxelmedicine.drugJournal of Clinical Oncology
researchProduct

Peripheral Neuropathy in the Hypereosinophilic Syndrome: A Case Report

1989

We observed a patient with the hypereosinophilic syndrome that showed as a prominent clinical feature peripheral nerve dysfunction. The neuropathy evolved over 4 months and affected sensory and motor functions. Nerve conduction studies and EMG were compatible with axonal neuropathy. Nerve and muscle biopsies revealed severe axonal degeneration with neurogenic atrophy of muscle. Morphometry of peroneal nerve showed marked axonal loss, more prominent in large myelinated fibers. There was no evidence of vasculitis process. Neuropathy is produced by eosinophil-released substances exerting a neurotoxic effect through direct altered vascular endothelial permeability and local mast cell histamine …

Pathologymedicine.medical_specialtyBiopsyAxonal losschemistry.chemical_compoundEosinophiliaBiopsymedicineHumansAxonmedicine.diagnostic_testHypereosinophilic syndromebusiness.industryPeripheral Nervous System DiseasesMiddle Agedmedicine.diseaseMast cellPeripheral neuropathymedicine.anatomical_structureNeurologychemistryImmunologyFemaleNeurology (clinical)businessVasculitisHistamineEuropean Neurology
researchProduct

Perifērās neiropātijas izmeklēšana hemodialīzes pacientiem

2018

Pamatinformācija: Hroniska nieru slimība (HNS) ir globāla veselības problēma, kuras vidējā izplatība Eiropā ir 18.4 %. Perifērā neiropātija (PN) ir visizplatītākā neiroloģiskā komplikācija (~ 60 līdz 100 %) šiem pacientiem. PN diagnoze ietver padziļinātu klīnisko izmeklēšanu, tai skaitā pacienta slimības vēstures analīzi, neiroloģisko izmeklēšanu, laboratorisko testēšanu un elektrofizioloģiskās izmeklēšanas metodes. Skrīninga metodes var palīdzēt agrīni noteikt PN HNS pacientiem un laicīgi sākt terapiju, mainot slimības attīstības gaitu. Mērķis: Noteikt perifēro neiropātiju HNS pacientiem ar Mičiganas neiropātijas skrīninga metodes (MNSI) palīdzību, kas apstiprināta un pielietota cukura dia…

Peripheral neuropathyHemodialysisChronic kidney diseaseMichigan neuropathy screening instrumentMedicīna
researchProduct

Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area

2015

Abstract Background: Familial amyloid polyneuropathy related to transthyretin gene (TTR-FAP) is a life-threatening disease transmitted as an autosomal dominant trait. Val30Met mutation accounts for the majority of the patients with large endemic foci especially in Portugal, Sweden and Japan. However, more than one hundred other mutations have been described worldwide. A great phenotypic variability among patients with late- and early-onset has been reported. Objective: To present a detailed report of TTR-FAP patients diagnosed in our tertiary neuromuscular center, in a 20-year period. Methods: Clinical informations were gathered through the database of our center. Results: The study involve…

Research ReportPediatricsmedicine.medical_specialtyPathologydysautonomiaCardiomyopathyLate onsetTTRtransthyretinmedicineFamilial amyloid polyneuropathy FAP transthyretin TTR amyloidosis cardiomyopathy dysautonomia epidemiology Italyamyloidosisbiologybusiness.industryAmyloidosisDysautonomiaAutosomal dominant traitFAPmedicine.diseaseTransthyretinPeripheral neuropathyNeurologyItalyFamilial amyloid polyneuropathybiology.proteinepidemiologyNeurology (clinical)medicine.symptombusinessPolyneuropathycardiomyopathyJournal of Neuromuscular Diseases
researchProduct